Aging population, is a reality in many countries because of improvement in the health care, patient safety and other supplemental factors. Pharmacotherapy in this population must be evaluated due to their higher susceptibility to adverse drug outcomes, like potential drug-drug interactions (PDDIs). | Epidemiology of potential drug-drug interactions in elderly population admitted to critical care units of Peshawar, Pakistan